FEMASYS INC (FEMY) Fundamental Analysis & Valuation

NASDAQ:FEMY • US31447E1055

Current stock price

0.4202 USD
+0.04 (+11.76%)
At close:
0.4324 USD
+0.01 (+2.9%)
Pre-Market:

This FEMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. FEMY Profitability Analysis

1.1 Basic Checks

  • FEMY had negative earnings in the past year.
  • In the past year FEMY has reported a negative cash flow from operations.
  • In the past 5 years FEMY always reported negative net income.
  • In the past 5 years FEMY always reported negative operating cash flow.
FEMY Yearly Net Income VS EBIT VS OCF VS FCFFEMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • FEMY has a Return On Assets of -121.55%. This is amonst the worse of the industry: FEMY underperforms 84.04% of its industry peers.
  • Looking at the Return On Equity, with a value of -434.59%, FEMY is doing worse than 82.45% of the companies in the same industry.
Industry RankSector Rank
ROA -121.55%
ROE -434.59%
ROIC N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
FEMY Yearly ROA, ROE, ROICFEMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

  • Looking at the Gross Margin, with a value of 63.05%, FEMY is in the better half of the industry, outperforming 67.55% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FEMY has declined.
  • FEMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
FEMY Yearly Profit, Operating, Gross MarginsFEMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. FEMY Health Analysis

2.1 Basic Checks

  • FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FEMY has more shares outstanding
  • FEMY has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for FEMY is higher compared to a year ago.
FEMY Yearly Shares OutstandingFEMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FEMY Yearly Total Debt VS Total AssetsFEMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of -13.69, we must say that FEMY is in the distress zone and has some risk of bankruptcy.
  • FEMY has a Altman-Z score of -13.69. This is amonst the worse of the industry: FEMY underperforms 86.17% of its industry peers.
  • A Debt/Equity ratio of 1.43 is on the high side and indicates that FEMY has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.43, FEMY is doing worse than 77.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z -13.69
ROIC/WACCN/A
WACC9.88%
FEMY Yearly LT Debt VS Equity VS FCFFEMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • FEMY has a Current Ratio of 1.16. This is a normal value and indicates that FEMY is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.16, FEMY is not doing good in the industry: 84.04% of the companies in the same industry are doing better.
  • FEMY has a Quick Ratio of 1.16. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of FEMY (0.61) is worse than 89.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.61
FEMY Yearly Current Assets VS Current LiabilitesFEMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. FEMY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.35% over the past year.
  • FEMY shows a strong growth in Revenue. In the last year, the Revenue has grown by 63.54%.
  • Measured over the past years, FEMY shows a quite strong growth in Revenue. The Revenue has been growing by 11.86% on average per year.
EPS 1Y (TTM)12.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)63.54%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%31.35%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.28% on average over the next years. This is quite good.
  • Based on estimates for the next years, FEMY will show a very strong growth in Revenue. The Revenue will grow by 97.39% on average per year.
EPS Next Y33.6%
EPS Next 2Y24.9%
EPS Next 3Y18.64%
EPS Next 5Y15.28%
Revenue Next Year-5.08%
Revenue Next 2Y54.21%
Revenue Next 3Y91.82%
Revenue Next 5Y97.39%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FEMY Yearly Revenue VS EstimatesFEMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
FEMY Yearly EPS VS EstimatesFEMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. FEMY Valuation Analysis

4.1 Price/Earnings Ratio

  • FEMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year FEMY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEMY Price Earnings VS Forward Price EarningsFEMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEMY Per share dataFEMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • FEMY's earnings are expected to grow with 18.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.9%
EPS Next 3Y18.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FEMY Dividend Analysis

5.1 Amount

  • No dividends for FEMY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FEMY Fundamentals: All Metrics, Ratios and Statistics

FEMASYS INC

NASDAQ:FEMY (3/31/2026, 8:00:00 PM)

Premarket: 0.4324 +0.01 (+2.9%)

0.4202

+0.04 (+11.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-26
Earnings (Next)05-06
Inst Owners10.59%
Inst Owner Change150.56%
Ins Owners8.3%
Ins Owner Change0%
Market Cap24.57M
Revenue(TTM)2.06M
Net Income(TTM)-19.80M
Analysts82.22
Price Target4.34 (932.84%)
Short Float %3.71%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.44%
Min EPS beat(2)18.3%
Max EPS beat(2)24.59%
EPS beat(4)2
Avg EPS beat(4)0.58%
Min EPS beat(4)-21.89%
Max EPS beat(4)24.59%
EPS beat(8)4
Avg EPS beat(8)-1.19%
EPS beat(12)6
Avg EPS beat(12)-1.81%
EPS beat(16)8
Avg EPS beat(16)2.91%
Revenue beat(2)0
Avg Revenue beat(2)-52.91%
Min Revenue beat(2)-55.12%
Max Revenue beat(2)-50.71%
Revenue beat(4)0
Avg Revenue beat(4)-60.47%
Min Revenue beat(4)-70.71%
Max Revenue beat(4)-50.71%
Revenue beat(8)0
Avg Revenue beat(8)-51.05%
Revenue beat(12)1
Avg Revenue beat(12)-38.6%
Revenue beat(16)3
Avg Revenue beat(16)-27.69%
PT rev (1m)-17.74%
PT rev (3m)-17.74%
EPS NQ rev (1m)2.78%
EPS NQ rev (3m)2.78%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-9.21%
Revenue NQ rev (3m)-9.21%
Revenue NY rev (1m)-2.77%
Revenue NY rev (3m)-2.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.92
P/FCF N/A
P/OCF N/A
P/B 5.39
P/tB 5.55
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.04
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -121.55%
ROE -434.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.05%
FCFM N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
F-Score2
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 158.29%
Cap/Sales 26.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.61
Altman-Z -13.69
F-Score2
WACC9.88%
ROIC/WACCN/A
Cap/Depr(3y)129.38%
Cap/Depr(5y)89.02%
Cap/Sales(3y)33.12%
Cap/Sales(5y)25.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y33.6%
EPS Next 2Y24.9%
EPS Next 3Y18.64%
EPS Next 5Y15.28%
Revenue 1Y (TTM)63.54%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%31.35%
Revenue Next Year-5.08%
Revenue Next 2Y54.21%
Revenue Next 3Y91.82%
Revenue Next 5Y97.39%
EBIT growth 1Y-1.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-81.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.49%
OCF growth 3YN/A
OCF growth 5YN/A

FEMASYS INC / FEMY Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FEMASYS INC (FEMY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to FEMY.


What is the valuation status of FEMASYS INC (FEMY) stock?

ChartMill assigns a valuation rating of 0 / 10 to FEMASYS INC (FEMY). This can be considered as Overvalued.


What is the profitability of FEMY stock?

FEMASYS INC (FEMY) has a profitability rating of 1 / 10.


How financially healthy is FEMASYS INC?

The financial health rating of FEMASYS INC (FEMY) is 0 / 10.